Male Birth Control Proved Successful In Baboons Could Be Available To Humans By 2017

, , , ,

Seth-in-Knocked-Up-seth-rogen-14600967-853-480Seth-in-Knocked-Up-seth-rogen-14600967-853-480

The world-changing miracle that is male birth control has proven successful in baboons and could be available for human use as soon as 2017.

It’s called Vasalgel, and unlike female birth control, it is entirely risk-free and requires just a single treatment.

First imagined by India’s Dr. Sujoy Guha over 15 years ago, Vasalgel involves a hydrogel that is injected into the vas deferens, in a virtually painless process.

This polymer blocks sperm from passing through the tube that would be severed during a vasectomy.

If the man wishes to conceive a child, the polymer is eliminated with a second injection.

Three male baboons were given Vasalgel in the latest study before having sex with 10 to 15 female baboons each over a six-month period.

None of the female baboons were impregnated.

These results, combined with a $50,000 gift from the David and Lucile Packard Foundation, will allow human trials to begin at some point next year.

The Parsemus Foundation, the not-for-profit organization developing the contraceptive, is confident the procedure will cost a few hundred dollars — much less than any long-lasting female contraceptives on the market today.

The potential impacts of Vasalgel are vast both on an individual and global scale, as long as price doesn’t become an issue.

Statistics from the Centers for Disease Control and Prevention state nearly half of all pregnancies in the US are accidental, and anyone who takes birth control pills is still risking heart disease, high blood pressure and nausea, just to name a few side effects.

Perhaps male birth control is the gateway to the pleasureful, worry-free life every man and woman wants, and in the years to come we’ll be wondering how anyone ever survived without it.

H/T: The Daily Beast, Photo Courtesy: Fanpop

Read more: http://elitedaily.com/news/world/male-birth-control-available-2017/747589/

Comments

comments

Comments are closed.